logo

Clinical Trial Calendar

Share
Company Name Prothena Corporation plc
Event Name Topline results from phase 2b trial of NEOD001 (PRONTO)
Indication Previously-treated patients with AL amyloidosis and persistent cardiac dysfunction
Outcome Date
Outcome
Result Date Early 2018
News
https://finance.yahoo.com/news/prothena-reports-third-quarter-2016-200602839.html
Return to Clinical Trial Calendar